loadpatents
name:-0.015758991241455
name:-0.012012958526611
name:-0.0013549327850342
Iizuka; Masato Patent Filings

Iizuka; Masato

Patent Applications and Registrations

Patent applications and USPTO patent grants for Iizuka; Masato.The latest application filed is for "fused heterocyclic derivative and pharmaceutical use thereof".

Company Profile
0.13.15
  • Iizuka; Masato - Matsumoto N/A JP
  • Iizuka; Masato - Azumino N/A JP
  • Iizuka; Masato - Matsumoto-shi JP
  • IIZUKA; Masato - Kanagawa JP
  • Iizuka; Masato - Azumino-shi JP
  • Iizuka; Masato - Nagano JP
  • Iizuka, Masato - Tokyo JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
(aza)indolizine derivative and pharmaceutical use thereof
Grant 9,643,969 - Iizuka , et al. May 9, 2
2017-05-09
5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
Grant 9,023,882 - Shimizu , et al. May 5, 2
2015-05-05
(aza)indole derivative and use thereof for medical purposes
Grant 8,993,616 - Shimizu , et al. March 31, 2
2015-03-31
Fused Heterocyclic Derivative And Pharmaceutical Use Thereof
App 20140296537 - Shimizu; Kazuo ;   et al.
2014-10-02
(aza)indole derivative and use thereof for medical purposes
Grant 8,829,040 - Shimizu , et al. September 9, 2
2014-09-09
Display Control Device, Display Control Method, And Recording Medium
App 20140189571 - IIZUKA; Masato
2014-07-03
(aza)indole Derivative And Use Thereof For Medical Purposes
App 20140179932 - Shimizu; Kazuo ;   et al.
2014-06-26
Indolizine derivative and use thereof for medical purposes
Grant 8,748,452 - Shimizu , et al. June 10, 2
2014-06-10
(aza)indole Derivative And Use Thereof For Medical Purposes
App 20130252955 - Shimizu; Kazuo ;   et al.
2013-09-26
(aza)indolizine Derivative And Pharmaceutical Use Thereof
App 20130217878 - Iizuka; Masato ;   et al.
2013-08-22
(aza)indole derivative and use thereof for medical purposes
Grant 8,466,152 - Shimizu , et al. June 18, 2
2013-06-18
5-membered Nitrogen Containing Heterocyclic Derivatives And Pharmaceutical Compositions Comprising The Same
App 20120289506 - Shimizu; Kazuo ;   et al.
2012-11-15
Fused-ring derivative and medical application of same
Grant 8,263,622 - Shimizu , et al. September 11, 2
2012-09-11
5-membered nitrogen containing heterocyclic derivatives and pharmaceutical compositions comprising the same
Grant 8,227,500 - Shimizu , et al. July 24, 2
2012-07-24
Indolizine Derivative And Use Thereof For Medical Purposes
App 20120015972 - Shimizu; Kazuo ;   et al.
2012-01-19
(aza)indole Derivative And Use Thereof For Medical Purposes
App 20110230454 - Shimizu; Kazuo ;   et al.
2011-09-22
Fused-ring Derivative And Medical Application Of Same
App 20110207935 - Shimizu; Kazuo ;   et al.
2011-08-25
(Aza)indole derivative and use thereof for medical purposes
Grant 8,003,647 - Shimizu , et al. August 23, 2
2011-08-23
Fused Heterocyclic Derivative And Use Thereof For Medical Purposes
App 20110201815 - Shimizu; Kazuo ;   et al.
2011-08-18
5-membered Heterocyclic Derivative And Use Thereof For Medical Purposes
App 20100227864 - Shimizu; Kazuo ;   et al.
2010-09-09
(aza)indole Derivative And Use Thereof For Medical Purposes
App 20100056521 - Shimizu; Kazuo ;   et al.
2010-03-04
Cellular phone, communication method and communication program
App 20040166892 - Iizuka, Masato
2004-08-26

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed